Peptide guide
What is PT-141?
Bremelanotide
By PacificRx editorial team · Updated · Educational, not medical advice
The short answer
PT-141 (bremelanotide) is a melanocortin-receptor agonist that acts in the brain on sexual desire. It is FDA-approved, as Vyleesi, for low sexual desire (hypoactive sexual desire disorder) in premenopausal women. Other uses are off-label, and a compounded preparation is not the approved product.
What is PT-141?
Bremelanotide works on melanocortin receptors in the brain rather than on blood flow, unlike erectile dysfunction medicines.
What the research shows
Randomized controlled trials in premenopausal women with HSDD showed modest improvements in desire and distress, leading to FDA approval in 2019.
Side effects and safety
Labeled side effects include nausea (common, especially with the first dose), flushing, headache and injection-site reactions. It can temporarily raise blood pressure, so it is not for people with uncontrolled high blood pressure or heart disease.
FDA and legal status
The active ingredient is FDA-approved (Vyleesi) for HSDD in premenopausal women. A compounded preparation is not FDA-approved and is not the branded product.
Questions
Is PT-141 the same as Vyleesi?
Vyleesi is the FDA-approved brand of bremelanotide (PT-141). A compounded preparation contains the same active ingredient but is not the branded product.
Can I get PT-141 online?
Only with a prescription. At PacificRx you complete an online intake, a clinician licensed in your state decides whether PT-141 is appropriate, and a licensed U.S. pharmacy prepares it for you. Medication starts at $149/month. Your card is charged only if you are approved. Avoid products sold as "research use only".